Response by Di Biase et al to Letter Regarding Article, "Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial".
暂无分享,去创建一个
S. Themistoclakis | P. Neužil | R. Schweikert | J. Burkhardt | A. Natale | M. Haissaguerre | L. Di Biase | P. Jais | R. Horton | P. Mohanty | Javier E. Sanchez | A. Dello Russo | S. Beheiry | C. Tondo | P. Santangeli | D. Lakkireddy | M. Casella | G. Pelargonio | S. Mohanty | C. Trivedi | A. Rossillo | S. Hao | M. Narducci | G. Forleo | R. Hongo | M. Reddy
[1] Dhanunjaya R. Lakkireddy,et al. Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial , 2016, Circulation.
[2] J. Healey,et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial. , 2014, JAMA.
[3] G. Hindricks,et al. Impact of single atrial fibrillation catheter ablation on implantable cardioverter defibrillator therapies in patients with ischaemic and non-ischaemic cardiomyopathies. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[4] John L Sapp,et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure. , 2010, The New England journal of medicine.
[5] David O. Martin,et al. Pulmonary-vein isolation for atrial fibrillation in patients with heart failure. , 2008, The New England journal of medicine.